EN
HI
Mankind Pharma share price chart
Mankind Pharma Share Key Metrics
Volume
83780.00
Market Cap
100688.42 CR
LTQ@LTP
24@2421.80
ATP
2422.31
Var Margin
14.51 %
Circuit Range
2194.2-2681.8
Delivery %
55.5 %
Value
20.29 CR
ASM/GSM
No
Market Lot
1
Summary
MANKIND stock price is ₹2421.8 as of 11 Aug, 2026. The stock intraday movement has stayed between ₹2412.00 and ₹2439.60, while Mankind Pharma share price 52 week high low is ₹1909.70 & ₹2674.00.
In terms of trading activity, MANKIND share price has recorded a volume of 83,780 shares. The Mankind Pharma has a market cap of ₹412995978. The stock’s Average Traded Price (ATP) stands at ₹2422.31, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 24 @ ₹2421.80.
The Mankind Pharma upper circuit limit is ₹2681.80 & The Mankind Pharma lower circuit limit is ₹2194.20, with a Value of ₹20.29 CR. The Delivery Percentage for the day is 55.5%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Mankind Pharma Fundamentals
P/E Ratio
49.29
P/B Ratio
5.99
Div. Yield
0
Sector P/E
64.83
Sector P/B
3.28
Sec. Div. Yield
0.51
Mankind Pharma Resistance and Support
Pivot 2450.5
Resistance
First Resistance
2472.5
Second Resistance
2507
Third Resistance
2529
Support
First Support
2416
Second Support
2394
Third Support
2359.5
Mankind Pharma Futures & Options
Mankind Pharma Option Chain
View Price, OI, Greeks & More...
25AUG26
2430.60
-14.80 (0.61%)
29SEP26
2435.50
-15.30 (0.62%)
27OCT26
2451.20
-12.80 (0.52%)
MANKIND|25AUG26 CE 2420.00
60.60
-6.9 (-10.22%)
MANKIND|25AUG26 PE 2440.00
55
3.45 (6.69%)
Mankind Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 11 2026 | 2429 | 2421.8 | -0.66% | 2439.6 | 2412 |
| Mon Aug 10 2026 | 2450 | 2438 | -0.73% | 2485 | 2428.5 |
| Fri Aug 07 2026 | 2430 | 2456 | 1.48% | 2456 | 2415.6 |
Mankind Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-31 | Quarterly Results & Interim Dividend |
| 2025-05-21 | Audited Results |
| 2025-01-23 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Mankind Pharma News
Mankind Pharma Ltd - 543904 - Board Meeting Outcome for For Appointment Of An Additional Director Designated As Non-Executive Independent Director
Mankind Pharma's Board appointed Anish Vanraj Bafna as an Additional Non-Executive Independent Director, effective August 10, 2026. He brings over 30 years of healthcare experience, including leadership roles at Healthium Medtech.
Aug 10 2026 16:10:07
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mankind Pharma announced participation in three investor conferences in August 2026. The management will engage with investors and analysts to discuss the general business outlook, ensuring no unpublished price sensitive information is disclosed.
Aug 10 2026 12:38:28
Read More
Mankind Pharma Management
| Name | Position |
|---|---|
| Hitesh Kumar Jain | Company Secretary & Compliance Officer |
| Ramesh Juneja | Chairman |
Mankind Pharma Similar Stocks
Apollo Hospitals Enterprise Ltd.
8790.00
-122.00 (1.37%)
Cipla Ltd.
1461.60
-6.10 (0.42%)
Zydus Lifesciences Ltd.
1142.10
23.10 (2.06%)
Lupin Ltd.
2264.90
-35.10 (1.53%)
Max Healthcare Institute Ltd.
1049.50
-19.50 (1.82%)
Laurus Labs Ltd.
1843.90
-10.10 (0.54%)
Lenskart Solutions Ltd.
586.80
0.65 (0.11%)
Dr. Reddy's Laboratories Ltd.
1156.50
-2.30 (0.20%)
Aurobindo Pharma Ltd.
1646.20
-1.80 (0.11%)
Mankind Pharma FAQs
The Buying Price of Mankind Pharma share is 2421.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mankind Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mankind Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mankind Pharma shares is 49.29. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mankind Pharma shares is 5.99. Useful to assess the stock's value relative to its book value.
To assess Mankind Pharma’s valuation compare Sector P/E, P/B which are 64.83 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mankind Pharma is 100688.42 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mankind Pharma share price is 2674.00 & 1909.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mankind Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
